05/10/2022

Farmaprojects becomes part of the Polpharma Group

After fifteen years of uninterrupted collaboration, Farmaprojects has been integrated into Polpharma Group, one of the 20 main global players in the generic market.

In 2006, Farmaprojects signed a strategic alliance with Polpharma, which was extended in 2013, becoming strategic partners in B2B area, covering both out-licensing and contract manufacturing.

Now, the integration is part of a broader consolidation of Polpharma Group combining all their businesses across CEE, Russia and CIS markets along with B2B.

Farmaprojects will be part of a group that is able to realize an ambitious growth plan over the next five years through a significant value growth from new launches underpinned with commercial and operational excellence. Currently, the company collaborates with more than 100 pharmaceutical companies in 50 countries around the world.

This operation allows Farmaprojects to offer a portfolio of high-quality B2B products and services: supply of active pharmaceutical ingredients, licensing of dossiers with supply of finished product, services of contract manufacturing, in addition to full support in pharmaceutical registration and intellectual property, among others.

Contact Sales Team